Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Remus Pharmaceuticals Ltd

REMUS.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$9.40

▲ +2.09%

Market Cap $110.80M · Vol 30.90K

Key Metrics

P/E Ratio

22.90

FWD: N/A

Market Cap

$110.80M

Micro Cap

Div Yield

0.11%

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

84.79

Momentum

Beta

N/A

vs Market

52W High

$9.97

13.90% below

52W Low

$6.08

51.52% above

Volume

30.90K

Avg 10.29K

P/B

2.11

Price-to-book

ROE

N/A

Return on equity

Free Float

N/A

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Remus Pharmaceuticals Ltd (REMUS.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does REMUS.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+6.54%

+25.00%

+24.45%

+32.45%

YTD

+27.79%

+1.54%

+35.85%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$91.34M
Net Income	$4.94M
Revenue Growth (YoY)	+30.42%
Gross Margin	12.73%
Operating Margin	6.32%
Net Profit Margin	5.41%
ROE	N/A
ROA · ROIC	11.70% · 10.59%

P/E Ratio	22.90
Forward P/E (FY1)	N/A
PEG Ratio	0.27
P/S	0.69
P/B	2.11
P/FCF	121.20
EPS Growth	N/A
Outstanding Shares	11.78M

Technical Indicators

50-Day SMA	$7.98
200-Day SMA	$7.46
RSI (14)	84.79
Beta	N/A
52-Week High	$9.97
52-Week Low	$6.08

Volume Today	30.90K
Avg Daily Volume (30D)	10.29K
Relative Volume	3.00x
Volatility (10D)	42.05
Volatility (30D)	36.50
Free Float	N/A

Analyst Consensus

N/A

Current Price $9.40

Mean Target N/A

52W Low$6.08 52W High$9.97

Current

Target

$6.08 $9.97

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG01GNDCRC3

ISININE0O5T01011

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Remus Pharmaceuticals Limited is an India-based company, which is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredients (APIs). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It offers a range of pharmaceutical formulations and products manufactured on contract manufacturing and on a loan license basis. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension and tablet. The Company offers its products in various therapeutic categories, such as oncology, cardiovascular, anti-diabetic, central nervous system (CNS), immunosuppressants, anti-biotic - antibacterial and dermatology.